UK tuberculosis diagnosis and treatment market are anticipated to grow at a CAGR around 0.8% during the forecast period. Early stages can be difficult to detect in the case of tuberculosis due to which the diagnostic and treatment can be delayed. Almost all forms of TB are treatable and curable; however, delays in diagnosis and treatment can result in less favorable outcomes for the individual and possible spread TB infection to other people. Tuberculosis screening test can be defined in many ways. The UK National Screening Committee is responsible for population screening and runs the national NHS screening programmes. It defines screening as a process of identifying apparently healthy people who are at increased risk of a tuberculosis disease or condition.
To Request a Sample of our Report on UK Tuberculosis Diagnosis and Treatment Market: https://www.omrglobal.com/request-sample/uk-tuberculosis-diagnosis-treatment-market
There are various types of screening for TB, including those aimed at detecting latent TB infection in people without symptoms, and those aiming to detect early active TB stage. These TB screening initiatives are not currently managed by the UK National Screening Committee, however, LTBI screening is recommended by NICE (National Institute for Health and Care) for people at higher risk of TB. The factors which have been contributing in the growth of the tuberculosis diagnostic and treatment market in UK are raising awareness among professionals and the public, or through active case finding of TB affecting the lungs. LTBI screening and active case finding support each other as public health activities which is also contributing in the growth of the market in the UK.
UK tuberculosis diagnosis and treatment market is segmented on the basis of drugs type and diagnosis. Based on drug type, the market is segmented into first line drugs and second line drugs. Based on diagnosis, the market is segmented into laboratory testing, nucleic acid amplification test, mantoux test, radiography and drug susceptibility testing.
(Get 15% Discount on Buying this Report)
A full Report of UK Tuberculosis Diagnosis and Treatment Market is Available @ https://www.omrglobal.com/industry-reports/uk-tuberculosis-diagnosis-treatment-market
UK Tuberculosis Diagnosis and Treatment Market Segmentation
By Drugs Type
- First Line Drugs
- Second Line Drugs
By Diagnosis
- Laboratory Testing
- Nucleic Acid Amplification Test
- Mantoux Test
- Radiography
- Drug Susceptibility Testing
Company Profiles
- Abbott Laboratories
- Becton, Dickinson and Co.
- Cepheid Inc
- Epistem Holdings PLC
- F. HOFFMANN-LA ROCHE LTD.
- GlaxoSmithKline PLC
- Johnson & Johnson
- Novartis AG
- Pifzer, Inc.
- Qiagen AG
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
